Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Ovarian Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT03373058
What this trial is testing

Efficacy of HIPEC in the Treatment of Advanced-Stage Epithelial Ovarian Cancer After Cytoreductive Surgery

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Affiliated Cancer Hospital & Institute of Guangzhou Medical University 310
Early research (Phase 1)Study completedNCT00045006
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07158021
What this trial is testing

Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+2 more
University of Michigan Rogel Cancer Center 75
Not applicableLooking for participantsNCT04891029
What this trial is testing

Early Detection of Endometrial/Ovarian Cancer and Hereditary Predisposition of These Cancers

Who this might be right for
Diagnoses Disease
McGill University 5,600
Large-scale testing (Phase 3)Looking for participantsNCT05659381
What this trial is testing

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Who this might be right for
Stage III Ovarian CancerStage IV Ovarian CancerStage III Primary Peritoneal Cancer+3 more
GOG Foundation 220
Testing effectiveness (Phase 2)Study completedNCT00410657
What this trial is testing

Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center 53
Large-scale testing (Phase 3)Active Not RecruitingNCT04095364
What this trial is testing

Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Low Grade Fallopian Tube Serous AdenocarcinomaOvarian Low Grade Serous AdenocarcinomaPrimary Peritoneal Low Grade Serous Adenocarcinoma+9 more
NRG Oncology 450
Testing effectiveness (Phase 2)Study completedNCT00880360
What this trial is testing

A Trial of Intravenous Denileukin Diftitox in Stage III or IV Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerExtraovarian Peritoneal CancerFallopian Tube Carcinoma
The University of Texas Health Science Center at San Antonio 19
Early research (Phase 1)WithdrawnNCT02470559
What this trial is testing

Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or Recurrent

Who this might be right for
Malignant Ovarian Clear Cell TumorMalignant Ovarian Serous TumorRecurrent Fallopian Tube Carcinoma+14 more
Barbara Ann Karmanos Cancer Institute
Large-scale testing (Phase 3)Study completedNCT00002717
What this trial is testing

Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group 324
Large-scale testing (Phase 3)Active Not RecruitingNCT02502266
What this trial is testing

Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Serous Adenocarcinoma+12 more
National Cancer Institute (NCI) 582
Not applicableActive Not RecruitingNCT05786456
What this trial is testing

E-Health Intervention (Day-by-Day) for the Management of Fear of Progression in Women With Stage III or IV Gynecologic Cancer: A Pilot Study

Who this might be right for
Malignant Female Reproductive System NeoplasmStage III Cervical Cancer AJCC v8Stage III Ovarian Cancer AJCC v8+8 more
City of Hope Medical Center 23
Testing effectiveness (Phase 2)Study completedNCT00003173
What this trial is testing

High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+5 more
Memorial Sloan Kettering Cancer Center 36
Not applicableLooking for participantsNCT01000259
What this trial is testing

Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer

Who this might be right for
Stage IIIA Ovarian CancerStage IIIB Ovarian CancerStage IIIC Ovarian Cancer+1 more
Gynecologic Oncology Group 174
Testing effectiveness (Phase 2)WithdrawnNCT00005645
What this trial is testing

ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment

Who this might be right for
Fallopian Tube CancerMetastatic CancerOvarian Cancer+1 more
Genzyme, a Sanofi Company
Testing effectiveness (Phase 2)Ended earlyNCT00034372
What this trial is testing

Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-Chemotherapy Consolidation for Ovarian Carcinoma

Who this might be right for
Ovarian Neoplasms
Unither Pharmaceuticals 102
Early research (Phase 1)WithdrawnNCT00118300
What this trial is testing

Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer

Who this might be right for
Cervical CancerEndometrial CancerOvarian Cancer+1 more
Case Comprehensive Cancer Center
Early research (Phase 1)UnknownNCT00527631
What this trial is testing

Adjuvant Whole Abdominal Intensity Modulated Radiotherapy (IMRT) for High Risk Stage FIGO III Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
Heidelberg University 8
Not applicableStudy completedNCT02704832
What this trial is testing

Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE)

Who this might be right for
Breast CancerColorectal CancerLung Cancer+4 more
Institut Bergonié 792
Testing effectiveness (Phase 2)WithdrawnNCT00085527
What this trial is testing

FR901228 in Treating Patients With Relapsed or Refractory Advanced Ovarian Epithelial Cancer

Who this might be right for
Ovarian Cancer
University of Chicago
Next Page